FA
MRNA icon

Fortis Advisors’s Moderna MRNA Stock Holding History

Fortis Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-28
Closed -$4K – 267
2022
Q2 		$4K Hold
28
– – ﹤0.01% 243
2022
Q1 		$5K Hold
28
– – ﹤0.01% 253
2021
Q4 		$7K Hold
28
– – ﹤0.01% 228
2021
Q3 		$11K Hold
28
– – 0.01% 219
2021
Q2 		$7K Hold
28
– – ﹤0.01% 235
2021
Q1 		$4K Buy
+28
New +$4.06K ﹤0.01% 211

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fortis Advisors's MRNA Position: Q3 2022 in Review

Fortis Advisors sold out of Moderna (MRNA) in Q3 2022, closing a stake of 28 shares — an estimated $4K sold.

Fortis Advisors first reported a position in MRNA in Q1 2021 and held it in 6 quarters. The position peaked at $11K in Q3 2021. 915 funds tracked by Wall St. Rank hold MRNA as of Q3 2022.

  • Fortis Advisors reported no remaining Moderna position as of Q3 2022 after selling out during the quarter.
  • Fortis Advisors sold 28 Moderna shares in Q3 2022, an estimated $4K.
  • Fortis Advisors first reported a position in Moderna in Q1 2021 and held it in 6 quarters.
  • Fortis Advisors's Moderna position peaked at $11K in Q3 2021.
  • 915 funds tracked by Wall St. Rank held Moderna as of Q3 2022.

Based on Fortis Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.